1,241 results on '"Yuasa Takeshi"'
Search Results
52. Characteristics of Long-Term and Short-Term Survivors of Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: Results From the International mRCC Database Consortium
53. Biomarkers to predict prognosis and response to checkpoint inhibitors
54. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups
55. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
56. A case of gastric metastasis from renal cell cancer during the sequential targeted therapy
57. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
58. Retrieving a lost needle in the descending aorta during hemi-arch replacement
59. Additional file 3 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
60. Additional file 2 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
61. Additional file 1 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
62. Data from TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression
63. Data Supplement from TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression
64. Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series
65. Editorial Comment to Plasma circulating tumor DNA profiling in patients with chemo‐refractory germ cell tumors
66. Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
67. Impact of number of treatment lines following first-line (1L) immuno-oncology (IO) combination on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).
68. Editorial Comment on Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study
69. First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium
70. The Processus Vaginalis Transection Method to Prevent Postradical Prostatectomy Inguinal Hernia: Long-term Results
71. Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab
72. Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
73. Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice
74. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab
75. A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
76. Editorial: Biomarkers in genitourinary cancers: Volume II
77. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma
78. Reply to Yudai Ishiyama and Fumihiko Urabe’s Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006
79. Spin Contrast Variation Study of Fuel-efficient Tire Rubber
80. Clinical outcome of urachal cancer in Japanese patients
81. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era
82. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery
83. ニッソ コッコウ カイフク コウショウ ケンキュウ ノ ゲンザイ
84. Editorial Comment to A case of steroid‐resistant cystitis as an immune‐related adverse event during treatment with nivolumab for lung cancer, which was successfully treated with infliximab
85. De novo large‐cell neuroendocrine carcinoma of the prostate: A case report and literature review
86. Editorial Comment to Clinicopathological features of adrenal malignancies: Analysis of hospital‐based cancer registry data in Japan
87. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging
88. Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel
89. Tumor Size Is a Potential Predictor of Response to Tyrosine Kinase Inhibitors in Renal Cell Cancer
90. Comparison of Medically Versus Surgically Treated Acute Type A Aortic Dissection in Patients
91. Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma
92. Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
93. Developments in personalized therapy for metastatic renal cell carcinoma
94. Editorial Comment from Dr Yuasa to Effect of active anticancer therapy on serologic response to SARS‐CoV ‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma
95. Recent Advances in Medical Therapy for Urological Cancers
96. DEVELOPMENT AND VALIDATION OF A NOVEL STEPWISE ALGORITHM USING CT AND MRI FOR DIAGNOSIS OF FAT-POOR ANGIOMYOLIPOMA IN SMALL RENAL MASSES: PD14-06
97. Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice.
98. Relationship Between Bone Mineral Density and Androgen-deprivation Therapy in Japanese Prostate Cancer Patients
99. Clinical Significance of Polymorphism and Expression of Chromogranin A and Endothelin-1 in Prostate Cancer
100. Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.